Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-4933

Expand medications allowed for patients with above normal BMI

    XMLWordPrintable

Details

    • EP/EC eCQMs
    • Status: Open
    • Moderate
    • Resolution: Unresolved
    • None

    Description

      Brief Description of Measure:
      ​CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan:
      Percentage of patients aged 18 years and older with a BMI documented during the current encounter or within the previous twelve months AND who had a follow-up plan documented if most recent BMI was outside of normal parameters

      Description of Issue:
      ​Based upon a recommendation made during the last annual update, the measure developer reviewed the list of medications currently included in the "Medications for Above Normal BMI" value set (OID: 2.16.840.1.113883.3.526.3.1561) with an expert work group. The expert work group agreed with the recommendations to revise the list to include all clinically appropriate medications.

      Proposed Solution:
      Add Plenity, Saxenda, Contrave, Naltrexone-bupropion, Benzphetamine, Phendimetrazine, and Wegovy to the "Medications for Above Normal BMI" value set (OID: 2.16.840.1.113883.3.526.3.1561). Specific codes will be identified later during the annual update.

      Rationale for Change:
      ​The expert work group recommended updating the "Medications for Above Normal BMI" value set to reflect all clinically appropriate medications for weight management.

      Attachments

        Activity

          People

            khancock Mathematica EC eCQM Team
            khancock Mathematica EC eCQM Team
            Votes:
            1 Vote for this issue
            Watchers:
            5 Start watching this issue

            Dates

              Created:
              Updated: